Ranbaxy Laboratories (LSE:RBXD) Debt-to-Asset : 0.43 (As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Ranbaxy Laboratories Debt-to-Asset?

Ranbaxy Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2014 was $662.2 Mil. Ranbaxy Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2014 was $323.6 Mil. Ranbaxy Laboratories's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2014 was $2,308.6 Mil. Ranbaxy Laboratories's debt to asset for the quarter that ended in Sep. 2014 was 0.43.

Ranbaxy Laboratories Debt-to-Asset Historical Data

The historical data trend for Ranbaxy Laboratories's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ranbaxy Laboratories Debt-to-Asset Chart

Ranbaxy Laboratories Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Debt-to-Asset

Get a 7-Day Free Trial

0.44

0.32

0.30

0.31

0.26

Ranbaxy Laboratories Quarterly Data
	Dec11	Dec12	Jun13	Sep14
Debt-to-Asset	0.26	0.29	0.40	0.43

Competitive Comparison of Ranbaxy Laboratories's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Ranbaxy Laboratories's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ranbaxy Laboratories's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ranbaxy Laboratories's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Ranbaxy Laboratories's Debt-to-Asset falls into.

Ranbaxy Laboratories Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Ranbaxy Laboratories's Debt-to-Asset for the fiscal year that ended in Dec. 2011 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(583.738	+	186.122)	/	3001.027
	=	0.26

Ranbaxy Laboratories's Debt-to-Asset for the quarter that ended in Sep. 2014 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(662.24	+	323.589)	/	2308.59
	=	0.43

Ranbaxy Laboratories (LSE:RBXD) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Ranbaxy Laboratories Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Ranbaxy Laboratories's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Ranbaxy Laboratories (LSE:RBXD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ranbaxy Laboratories Ltd (LSE:RBXD) » Definitions » Debt-to-Asset

Traded in Other Exchanges

N/A

Address

Website

http://www.ranbaxy.com

Ranbaxy Laboratories Ltd., is an integrated international pharmaceuticals company. It markets, produces and distributes pharmaceuticals products.

Ranbaxy Laboratories (LSE:RBXD) Headlines

No Headlines